Eledon pharmaceuticals to participate at the 2023 cantor fitzgerald global healthcare conference

Irvine, calif., sept. 20, 2023 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today announced that david-alexandre c. gros, m.d., chief executive officer, and steve perrin, ph.d., president and chief scientific officer, will participate in a panel presentation at the upcoming cantor fitzgerald global healthcare conference on wednesday, september 27, 2023, at 8:00 a.m. et.
ELDN Ratings Summary
ELDN Quant Ranking